Return to Article Details
FUTURE CHALLENGES AND EMERGING SAFETY CONCERNS OF GLP-1 RECEPTOR AGONISTS, DUAL INCRETIN AGONISTS, AND SGLT2 INHIBITORS
Download
Download PDF